Merrill Lynch Upgrades PharMerica (PMC) to Buy
More News related to PMC
- PharMerica Reports the Amending and Restating of the Master Pharmacy Provider Agreement with Kindred Healthcare Operating, Inc.
- PharMerica to Present at 2008 Annual Credit Suisse Health Care Conference
- PharMerica (PMC) Reports Q3 EPS of $0.27, Beats by 7c; Guides FY08
- PharMerica Reports Results for the Third Quarter 2008 and for the Nine Months Ended September 30, 2008 and Updates Earnings Guidance
- PharMerica to Present at Oppenheimer & Co. 19th Annual Healthcare Conference
More News related to Upgrades
- Raymond James Starts Millicom (MICC) at Strong Buy
- Stifel Nicolaus Starts City National (CYN) at Hold
- Stifel Nicolaus Starts eHealth (Nasdaq: HLTH) with a Buy
- Wasserman & Associates initiates coverage on American Physicians Service Group (AMPH) with a Buy
- Jesup & Lamont Initiates Coverage on AutoZone (AZO) with a Hold.
Merrill Lynch upgrades PharMerica (NYSE: PMC) from Neutral to Buy.
PharMerica Corporation is an institutional pharmacy services company.
Related Categories
UpgradesStocks Mentioned
-1.58Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
